Directorate change

Summary by AI BETAClose X

JPMorgan Claverhouse Investment Trust plc announced the death of Non-Executive Director Joanne Fintzen, who joined the Board in 2022. The company expressed deep sadness and acknowledged her invaluable contributions through her experience, insight, and sound judgment during her tenure. The Board and staff will miss her wisdom, warmth, and commitment, extending heartfelt condolences to her family and loved ones.

Disclaimer*

JPMorgan Claverhouse IT PLC
18 September 2026
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

                               JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

Announcement of the Death of Non-Executive Director

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R

 

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is deeply saddened to announce the death of Joanne Fintzen, a Non-Executive Director of the Company. Jo joined the Board in 2022 and throughout her tenure, made an invaluable contribution through her experience, insight and sound judgement.

 

Victoria Stewart, Chair of the Company, said:

"On behalf of the Board and everyone at the Company, I would like to express our profound sadness at the loss of Jo. She demonstrated remarkable dedication and resilience throughout her service and was a much-valued colleague whose wisdom, warmth and commitment made a lasting contribution to the Company. She will be missed by her colleagues and by all who had the privilege of working with her. Our heartfelt condolences are with her family, friends and loved ones at this very difficult time."

 

 

18th September 2026

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings